Skip to main content
Top
Published in: Respiratory Research 1/2018

Open Access 01-12-2018 | Letter to the Editor

The diagnostic performance of patient symptoms in screening for COPD

Published in: Respiratory Research | Issue 1/2018

Login to get access

Abstract

It is recommended that screening for COPD be restricted to symptomatic individuals, but supporting evidence is lacking. We determined the performance of wheeze, cough, phlegm, and dyspnea in discriminating COPD versus non-COPD in a population-based sample of 1332 adults. Area Under the Receiver Operating Curves (AUC) indicated that symptoms had modest performance whether assessed individually (AUCs 0.55–0.62), or in combination (AUC for number of symptoms as the predictor 0.64). AUC improved with the inclusion of multiple other factors (AUC 0.71). Restricting screening to symptomatic individuals is unlikely to substantially improve the yield of general population screening for undiagnosed COPD.
Literature
1.
go back to reference From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet]. 2017 [cited 2017 May 1]. Available from: http://goldcopd.org From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet]. 2017 [cited 2017 May 1]. Available from: http://​goldcopd.​org
2.
go back to reference Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.CrossRefPubMed Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.CrossRefPubMed
3.
go back to reference Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155:179–91.CrossRefPubMed Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155:179–91.CrossRefPubMed
4.
go back to reference US Preventive Services Task Force (USPSTF), Siu AL, Bibbins-Domingo K, Grossman DC, Davidson KW, Epling JWJ, et al. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:1372–7.CrossRef US Preventive Services Task Force (USPSTF), Siu AL, Bibbins-Domingo K, Grossman DC, Davidson KW, Epling JWJ, et al. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:1372–7.CrossRef
5.
go back to reference Kaplan A, Thomas M. Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017;26:160113.CrossRefPubMed Kaplan A, Thomas M. Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017;26:160113.CrossRefPubMed
6.
go back to reference Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2018;19:26.CrossRefPubMedPubMedCentral Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2018;19:26.CrossRefPubMedPubMedCentral
7.
go back to reference Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax. 2014;69:709–17.CrossRefPubMedPubMedCentral Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax. 2014;69:709–17.CrossRefPubMedPubMedCentral
8.
go back to reference Bourbeau J, Tan WC, Benedetti A, Aaron SD, Chapman KR, Coxson HO, et al. Canadian cohort obstructive lung disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD. 2014;11:125–32.CrossRefPubMed Bourbeau J, Tan WC, Benedetti A, Aaron SD, Chapman KR, Coxson HO, et al. Canadian cohort obstructive lung disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD. 2014;11:125–32.CrossRefPubMed
9.
go back to reference Pepe MS. Evaluating technologies for classification and prediction in medicine. Stat Med. 2005;24:3687–96.CrossRefPubMed Pepe MS. Evaluating technologies for classification and prediction in medicine. Stat Med. 2005;24:3687–96.CrossRefPubMed
10.
go back to reference Stanley AJ, Hasan I, Crockett AJ, van Schayck OCP, Zwar NA. COPD diagnostic questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24:14024.CrossRefPubMedPubMedCentral Stanley AJ, Hasan I, Crockett AJ, van Schayck OCP, Zwar NA. COPD diagnostic questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24:14024.CrossRefPubMedPubMedCentral
11.
go back to reference Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D’Eletto T, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD J Chronic Obstr Pulm Dis. 2008;5:85–95.CrossRef Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D’Eletto T, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD J Chronic Obstr Pulm Dis. 2008;5:85–95.CrossRef
12.
go back to reference Gershon AS, Hwee J, Chapman KR, Aaron SD, O’Donnell DE, Stanbrook MB, et al. Factors associated with undiagnosed and overdiagnosed COPD. Eur Respir J. 2016;48:561–4.CrossRefPubMed Gershon AS, Hwee J, Chapman KR, Aaron SD, O’Donnell DE, Stanbrook MB, et al. Factors associated with undiagnosed and overdiagnosed COPD. Eur Respir J. 2016;48:561–4.CrossRefPubMed
Metadata
Title
The diagnostic performance of patient symptoms in screening for COPD
Publication date
01-12-2018
Published in
Respiratory Research / Issue 1/2018
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-018-0853-5

Other articles of this Issue 1/2018

Respiratory Research 1/2018 Go to the issue